191 related articles for article (PubMed ID: 36125843)
21. Tumor cell membrane-based peptide delivery system targeting the tumor microenvironment for cancer immunotherapy and diagnosis.
Meng X; Wang J; Zhou J; Tian Q; Qie B; Zhou G; Duan W; Zhu Y
Acta Biomater; 2021 Jun; 127():266-275. PubMed ID: 33813091
[TBL] [Abstract][Full Text] [Related]
22. Magnetite Fe
Li S; Liu Y; Liu X; Lan B; Li W; Guo F
Int J Nanomedicine; 2021; 16():6129-6140. PubMed ID: 34511910
[TBL] [Abstract][Full Text] [Related]
23. Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy.
Shi M; Zhang J; Wang Y; Han Y; Zhao X; Hu H; Qiao M; Chen D
Acta Biomater; 2022 Sep; 150():353-366. PubMed ID: 35843594
[TBL] [Abstract][Full Text] [Related]
24. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
[TBL] [Abstract][Full Text] [Related]
25. Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer.
Zhao P; Xu Y; Ji W; Zhou S; Li L; Qiu L; Qian Z; Wang X; Zhang H
J Nanobiotechnology; 2021 Jun; 19(1):181. PubMed ID: 34120612
[TBL] [Abstract][Full Text] [Related]
26. An Intelligent Vascular Disrupting Dendritic Nanodevice Incorporating Copper Sulfide Nanoparticles for Immune Modulation-Mediated Combination Tumor Therapy.
Zhang Y; Ouyang Z; Zhan M; Yang R; Gao Y; Li L; Guo R; Shi X; Cao X
Small; 2023 Sep; 19(39):e2301914. PubMed ID: 37259269
[TBL] [Abstract][Full Text] [Related]
27. Near-Infrared Responsive Membrane Nanovesicles Amplify Homologous Targeting Delivery of Anti-PD Immunotherapy against Metastatic Tumors.
Tan YN; Huang JD; Li YP; Li SS; Luo M; Luo J; Lee AW; Fu L; Hu FQ; Guan XY
Adv Healthc Mater; 2022 Mar; 11(6):e2101496. PubMed ID: 34878725
[TBL] [Abstract][Full Text] [Related]
28. Semiconducting Polymer Nanoparticles with Surface-Mimicking Protein Secondary Structure as Lysosome-Targeting Chimaeras for Self-Synergistic Cancer Immunotherapy.
Qi J; Jia S; Kang X; Wu X; Hong Y; Shan K; Kong X; Wang Z; Ding D
Adv Mater; 2022 Aug; 34(31):e2203309. PubMed ID: 35704513
[TBL] [Abstract][Full Text] [Related]
29. Tumor targeting and penetrating biomimetic mesoporous polydopamine nanoparticles facilitate photothermal killing and autophagy blocking for synergistic tumor ablation.
Huang X; Chen L; Lin Y; Tou KI; Cai H; Jin H; Lin W; Zhang J; Cai J; Zhou H; Pi J
Acta Biomater; 2021 Dec; 136():456-472. PubMed ID: 34562660
[TBL] [Abstract][Full Text] [Related]
30. Paraptosis Inducer to Effectively Trigger Immunogenic Cell Death for Metastatic Tumor Immunotherapy with IDO Inhibition.
Zheng RR; Zhao LP; Huang CY; Cheng H; Yang N; Chen ZX; Cai H; Zhang W; Kong RJ; Li SY
ACS Nano; 2023 Jun; 17(11):9972-9986. PubMed ID: 37200049
[TBL] [Abstract][Full Text] [Related]
31. Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition.
Ismail M; Yang W; Li Y; Wang Y; He W; Wang J; Muhammad P; Chaston TB; Rehman FU; Zheng M; Lovejoy DB; Shi B
Biomaterials; 2022 Oct; 289():121760. PubMed ID: 36044788
[TBL] [Abstract][Full Text] [Related]
32. A Biomimetic Metal-Organic Framework Nanosystem Modulates Immunosuppressive Tumor Microenvironment Metabolism to Amplify Immunotherapy.
Wang H; Wu C; Tong X; Chen S
J Control Release; 2023 Jan; 353():727-737. PubMed ID: 36473607
[TBL] [Abstract][Full Text] [Related]
33. Pre-Induced ICD Membrane-Coated Carrier-Free Nanoparticles for the Personalized Lung Cancer Immunotherapy.
Li S; Jiang S; Rahman MSU; Mei J; Wang X; Jiang J; Chen Y; Xu S; Liu Y
Small Methods; 2023 May; 7(5):e2201569. PubMed ID: 36932898
[TBL] [Abstract][Full Text] [Related]
34. Multifunctional PVCL nanogels with redox-responsiveness enable enhanced MR imaging and ultrasound-promoted tumor chemotherapy.
Xu F; Zhu J; Lin L; Zhang C; Sun W; Fan Y; Yin F; van Hest JCM; Wang H; Du L; Shi X
Theranostics; 2020; 10(10):4349-4358. PubMed ID: 32292499
[TBL] [Abstract][Full Text] [Related]
35. Atovaquone-HSA nano-drugs enhance the efficacy of PD-1 blockade immunotherapy by alleviating hypoxic tumor microenvironment.
Wang S; Zhou X; Zeng Z; Sui M; Chen L; Feng C; Huang C; Yang Q; Ji M; Hou P
J Nanobiotechnology; 2021 Oct; 19(1):302. PubMed ID: 34600560
[TBL] [Abstract][Full Text] [Related]
36. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
37. A multifunctional CaCO
Chen W; Lu Y; Sun X; Leng J; Lin S; He X; Zhang C; Yuan C
J Control Release; 2024 Apr; 368():780-796. PubMed ID: 38499091
[TBL] [Abstract][Full Text] [Related]
38. Tailor-Made Autophagy Cascade Amplification Polymeric Nanoparticles for Enhanced Tumor Immunotherapy.
Long X; Wang H; Yan J; Li Y; Dong X; Tian S; Sun Y; Luo K; He B; Liang Y
Small; 2023 Jun; 19(24):e2207898. PubMed ID: 36932938
[TBL] [Abstract][Full Text] [Related]
39. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
[TBL] [Abstract][Full Text] [Related]
40. Metabolic reprogramming by dual-targeting biomimetic nanoparticles for enhanced tumor chemo-immunotherapy.
Zang S; Huang K; Li J; Ren K; Li T; He X; Tao Y; He J; Dong Z; Li M; He Q
Acta Biomater; 2022 Aug; 148():181-193. PubMed ID: 35649505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
